• Friday, March 29, 2024

Business

Barclays CEO CS Venkatakrishnan to undergo cancer treatment but will ‘continue to be actively engaged’

By: Shubham Ghosh

British bank Barclays on Monday (28) said that its chief executive officer CS Venkatakrishnan would be undergoing treatment for non-Hodgkin lymphoma, a type of cancer, and that would mean it would work from home for some time.

According to a Reuters report, Venkatakrishnan, who was born in India, said in a letter that his condition was curable and that the doctors lauded his prognosis, with the treatment in New York expected to last between 12 and 16 weeks, Reuters reported.

“During this period, the company will run normally, and I will continue to be actively engaged in managing it,” Venkatakrishnan, who is known in the bank as Venkat, said in the letter.

A spokesperson for the bank said Barclays had not appointed any interim chief executive and that Venkat and the lender’s executive committee were expected to continue running it, the report added.

Non-Hodgkin lymphoma is a cancer that develops in the lymphatic system and weakens the immune system, but most cases are considered “very treatable”, according to the website of Britain’s National Health Service.

Related Stories

Loading